Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10180925 | 0.94 | NAAA (0.33) | NAAALMNAMAPTPTGS2 | |
| SCHEMBL28879070 | 0.90 | NAAA (0.34) | NAAALMNAMAPTPTGS2PRKCA | |
| SCHEMBL194536 | 0.86 | NAAA (0.47) | NAAALMNAMAPTSTAT3AR | |
| SCHEMBL28542236 | 0.86 | NAAA (0.47) | NAAALMNAMAPTSTAT3AR | |
| SCHEMBL194331 | 0.82 | NAAA (0.42) | NAAALMNAMAPTSTAT3PRKCA | |
| SCHEMBL3632141 | 0.82 | NAAA (0.43) | NAAALMNAMAPT | |
| SCHEMBL9374247 | 0.81 | DGKA (0.43) | NAAASTAT3PRKCA | |
| SCHEMBL28535600 | 0.80 | NAAA (0.58) | NAAALMNAMAPTSTAT3PRKCA | |
| SCHEMBL39244 | 0.79 | NAAA (0.48) | NAAALMNAPRKCA | |
| SCHEMBL6298154 | 0.79 | NAAA (0.48) | NAAALMNAPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | OGG1, POLH, OGFOD1 | NAAA 925/4885LMNA 419/4885MAPT 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.